When is amiodarone recommended by guidelines for rate control in patients with atrial fibrillation (Afib) (AF)?

Updated: Nov 18, 2019
  • Author: Lawrence Rosenthal, MD, PhD, FACC, FHRS; Chief Editor: Jeffrey N Rottman, MD  more...
  • Print

Amiodarone has a class IIa recommendation from the 2014 American College of Cardiology (ACC)/American Heart Association (AHA)/Heart Rhythm Society (HRS) for use as a rate-controlling agent for patients who are intolerant of or unresponsive to other agents, such as patients with congestive heart failure (CHF) who may otherwise not tolerate diltiazem or metoprolol. [1] Caution should be exercised in those who are not receiving anticoagulation, as amiodarone can promote cardioversion.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!